phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Blood Pressure, Low in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Az'muko, AA; Bespalova, ZhD; Efremov, EE; Kapel'ko, VI; Lakomkin, SV; Lakomkin, VL; Molokoedov, AS; Orlova, TsR; Sharf, TV; Sidorova, MV | 1 |
Harris, KH; Jhamandas, JH; Jhamandas, KH; Petrov, T; Yang, HY | 1 |
2 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Blood Pressure, Low
Article | Year |
---|---|
[Modification of the FF neuropeptide enhances its hypertensive effect].
Topics: Animals; Autoantibodies; Blood Pressure; Female; Heart Rate; Hypertension; Hypotension; Male; Oligopeptides; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Neuropeptide; Shock, Hemorrhagic | 2009 |
Activation of neuropeptide FF neurons in the brainstem nucleus tractus solitarius following cardiovascular challenge and opiate withdrawal.
Topics: Angiotensin II; Animals; Hemodynamics; Hypertension; Hypotension; Male; Morphine; Morphine Dependence; Naloxone; Neurons; Nitroprusside; Oligopeptides; Phenylephrine; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Solitary Nucleus; Substance Withdrawal Syndrome | 1998 |